EYEZIRGAN
EYEZIRGAN
Approved
DIN Number
02530546
Drug Class
Human
Market Date
Sep 26, 2023
Company
HC
LABORATOIRES THEA
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02530546
AIG Number0128037004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01AD09 GANCICLOVIR
Product Specifications
Dosage FormGel
Route of AdministrationOphthalmic
AHFS Classification52:04.20
Health Canada Classification
ACTIVE INGREDIENTS (1)
GANCICLOVIRActive
Strength: 0.15 % / W/W
Monograph: GANCICLOVIR